| Product Name | Siponimod - API |
| Product Code | DA-S211-a |
| Chemical name | Siponimod |
| Synonyms | Mayzent; BAF 312; 1-({4-[(1E)-1-({[4-Cyclohexyl- 3-(trifluoromethyl)phenyl]methoxy}imino)ethyl]-2-ethylphenyl}methyl)azetidine-3-carboxylic Acid; 1-(4-[1-[(E)-4-Cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl]-2-ethyl-benzyl)-azetidine-3-carboxylic Acid; (E)-1-(4-(1-(((4-cyclohexyl-3-(trifluoromethyl)benzyl)oxy)imino)ethyl)-2-ethylbenzyl)azetidine-3-carboxylic Acid; |
| Impurity | NA |
| CAS Number | 1230487-00-9 |
| Alternate CAS # | NA |
| Molecular form | C29H35F3N2O3 |
| Appearance | White to Off-White Solid |
| Melting Point | NA |
| Mol. Weight | 516.61 |
| Storage | 2-8°C Hygroscopic, Refrigerator, Under Inert Atmosphere |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Siponimod is a functional sphingosine -1 phosphate (SIP) antagonist used in the treatment of multiple sclerosis and other central nervous system-related diseases in human subjects. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
